ScholarIQanswers from OpenAlex

The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder

PaperCitations, authors & open-access status

The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder have?

ScholarIQcitation count

The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder has 232 citations in the OpenAlex counts ScholarIQ stores.

When was The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder published?

ScholarIQyear

The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder has 2012 year in the ScholarIQ index.

What is the open-access status of The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder?

ScholarIQoa status

The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder has bronze oa status in the ScholarIQ index.

What is the DOI of The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder?

ScholarIQdoi

The DOI for The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder is on the source record.

What is the PMID of The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder?

ScholarIQpmid

The PMID for The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder is on the source record.

What is the OpenAlex record for The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder?

ScholarIQopenalex

The OpenAlex for The C9ORF72 expansion mutation is a common cause of ALS+/−FTD in Europe and has a single founder is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial